| Primary |
| Arthritis |
16.3% |
| Back Pain |
14.3% |
| Arthralgia |
9.2% |
| Headache |
8.4% |
| Pain |
8.4% |
| Analgesic Therapy |
8.0% |
| Hypertension |
6.8% |
| Product Used For Unknown Indication |
6.8% |
| Prophylaxis |
6.0% |
| Rheumatoid Arthritis |
5.2% |
| Routine Health Maintenance |
2.0% |
| Multiple Sclerosis |
1.6% |
| Muscle Spasms |
1.2% |
| Toothache |
1.2% |
| Arthropathy |
0.8% |
| Back Disorder |
0.8% |
| Bone Pain |
0.8% |
| Constipation |
0.8% |
| Joint Swelling |
0.8% |
| Musculoskeletal Pain |
0.8% |
|
| No Adverse Event |
37.6% |
| Back Pain |
8.3% |
| Abdominal Discomfort |
6.0% |
| Pain |
6.0% |
| Arthralgia |
4.5% |
| Headache |
4.5% |
| Nausea |
3.8% |
| Pruritus |
3.8% |
| Foreign Body |
3.0% |
| Diarrhoea |
2.3% |
| Dizziness |
2.3% |
| Drug Ineffective |
2.3% |
| Dysgeusia |
2.3% |
| Dyspnoea |
2.3% |
| Haematochezia |
2.3% |
| Upper Gastrointestinal Haemorrhage |
2.3% |
| Urticaria |
2.3% |
| Abdominal Pain Upper |
1.5% |
| Adverse Event |
1.5% |
| Arthritis |
1.5% |
|
| Secondary |
| Pain |
21.6% |
| Arthritis |
16.2% |
| Product Used For Unknown Indication |
10.2% |
| Fibromyalgia |
5.9% |
| Hypertension |
4.9% |
| Back Pain |
4.0% |
| Joint Swelling |
3.8% |
| Oedema Peripheral |
3.8% |
| Headache |
3.3% |
| Arthralgia |
3.2% |
| Cardiac Disorder |
2.9% |
| Myalgia |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Nasopharyngitis |
2.5% |
| Smoking Cessation Therapy |
2.4% |
| Swelling |
2.4% |
| Medical Diet |
2.2% |
| Analgesic Therapy |
1.7% |
| Diabetes Mellitus |
1.7% |
| Muscle Spasms |
1.7% |
|
| Drug Ineffective |
24.6% |
| No Adverse Event |
13.2% |
| Gastrointestinal Haemorrhage |
7.0% |
| Pain |
7.0% |
| Drug Hypersensitivity |
5.3% |
| Nausea |
5.3% |
| Back Pain |
3.5% |
| Headache |
3.5% |
| Oedema Peripheral |
3.5% |
| Vomiting |
3.5% |
| Abdominal Discomfort |
2.6% |
| Anaphylactic Reaction |
2.6% |
| Arthralgia |
2.6% |
| Arthritis |
2.6% |
| Burning Sensation |
2.6% |
| Insomnia |
2.6% |
| Rectal Haemorrhage |
2.6% |
| Blister |
1.8% |
| Chest Pain |
1.8% |
| Depression |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.4% |
| Pain |
9.1% |
| Contraception |
6.7% |
| Hypertension |
5.1% |
| Rheumatoid Arthritis |
4.4% |
| Multiple Sclerosis |
4.3% |
| Acne |
4.1% |
| Depression |
4.0% |
| Headache |
3.8% |
| Premenstrual Syndrome |
3.5% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Premedication |
2.8% |
| Osteoporosis |
2.6% |
| Anxiety |
2.4% |
| Back Pain |
2.2% |
| Arthralgia |
2.1% |
| Arthritis |
2.1% |
| Migraine |
2.0% |
| Non-small Cell Lung Cancer |
2.0% |
| Asthma |
1.9% |
|
| Pain |
16.7% |
| Deep Vein Thrombosis |
6.9% |
| Injury |
6.9% |
| Drug Ineffective |
5.8% |
| Anxiety |
5.6% |
| Nausea |
5.6% |
| Pulmonary Embolism |
5.6% |
| Cholelithiasis |
5.4% |
| Pain In Extremity |
4.5% |
| Fatigue |
4.3% |
| Dyspnoea |
3.6% |
| Injection Site Pain |
3.6% |
| Pneumonia |
3.6% |
| Cholecystitis Chronic |
3.4% |
| Abdominal Pain |
3.2% |
| Abdominal Pain Upper |
3.2% |
| Emotional Distress |
3.2% |
| Death |
3.0% |
| Depression |
3.0% |
| Flushing |
3.0% |
|
| Interacting |
| Arthralgia |
25.0% |
| Hypertension |
25.0% |
| Prophylaxis |
25.0% |
| Depression |
6.3% |
| Encephalopathy |
6.3% |
| Lip Swelling |
6.3% |
| Migraine |
6.3% |
|
| Dyspnoea |
25.0% |
| Haemolytic Anaemia |
25.0% |
| Lip Swelling |
25.0% |
| Upper Gastrointestinal Haemorrhage |
25.0% |
|
